Arhaus reported record Q2 net revenue of $385 million, a 7.4% increase year-over-year, driven by strong customer demand and a 12.5% rise in comparable sales. Earnings per share of $0.28 beat estimates by 75%, supported by a 16.1% increase in gross margin to $172 million, including a $23.8 million tariff refund. Following these results, an analyst upgraded Arhaus to a Buy rating with a $12 price target, implying a 24% upside from the current $9.68 stock price. The company benefits from sustained demand for premium home furnishings, especially upholstery, outdoor products, and customization services, signaling continued growth momentum.
Flutter Entertainment's stock dropped 13% following a significant earnings miss and the announcement of CEO Peter Jackson's departure. The company reported Q2 earnings of $0.49 per share, well below the expected $0.60, and cut its full-year U.S. prof...
Attovia Therapeutics, a clinical-stage biopharmaceutical company, completed an upsized IPO by selling 19.55 million shares, including an underwriter option, raising approximately $332.40 million. The stock opened at $21.00 per share on Nasdaq and rea...
Aflac reported Q2 2026 earnings per share of $1.75, slightly below analyst estimates, while revenue of $4.12 billion narrowly exceeded projections. The company's improved profitability in Japan, highlighted by a better benefit-to-premium ratio of 61....
YXT.COM Group Holding Limited's stock plunged 66.07% following a registered direct offering that raised concerns about share dilution. The leveraged ETF Tradr 2X Long APP Daily ETF (APPX) fell 39.22%, highlighting the risks of leveraged products. Des...
Sanuwave Health reported Q2 2026 revenue of $9.7 million, down 3% from $10.1 million in Q2 2025, with a net loss of $0.7 million compared to net income last year. The company faced challenges from CMS reimbursement changes and a secondary market for ...
